Airway clearance therapy is an essential component of care for individuals with chronic respiratory conditions that impair mucus clearance, such as cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. When mucus accumulates in the airways, it creates an environment conducive to infection, inflammation, and progressive lung damage. Patients may experience persistent cough, recurrent respiratory infections, reduced exercise tolerance, and shortness of breath. Effective airway clearance therapy improves ventilation, reduces infection risk, and helps maintain lung function over time. Assessment typically includes evaluation of lung function, sputum characteristics, and patient ability to perform clearance techniques.
Treatment strategies involve both manual and mechanical methods tailored to individual needs. Manual techniques include postural drainage, percussion, and breathing exercises, while mechanical methods encompass high-frequency chest wall oscillation, positive expiratory pressure devices, and oscillatory vests. Pulmonary rehabilitation programs often integrate airway clearance therapy with exercise and breathing training to enhance overall respiratory efficiency. Hydration, mucolytic agents, and inhaled medications may further facilitate mucus mobilization. Education and adherence support are critical, ensuring that patients and caregivers can perform techniques safely and consistently. Regular monitoring of symptoms, lung function, and infection markers allows clinicians to adjust therapy as needed. By implementing comprehensive airway clearance therapy, patients can reduce exacerbations, preserve lung capacity, and improve quality of life, making it a cornerstone in managing chronic airway diseases.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal